Data as of 3:58pm ET
| +0.37 / +1.66%|
The 4 analysts offering 12-month price forecasts for Emergent BioSolutions Inc have a median target of 24.00, with a high estimate of 30.00 and a low estimate of 20.00. The median estimate represents a +5.63% increase from the last price of 22.72.
The current consensus among 4 polled investment analysts is to Buy stock in Emergent BioSolutions Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.